Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan Blokland

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Behavioural Pharmacology|May 27, 2022
Cholinergic models of memory impairment in animals and man: scopolamine vs. biperidenArjan Blokland
Human Psychopharmacology|May 4, 2023
Can placebo or nocebo pills improve or impair cognition performance?Arjan Blokland
Psychopharmacology|February 22, 2011
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentInge Klinkenberg, Arjan Blokland
Expert Opinion on Drug Discovery|March 20, 2013
Use of behavioural and long-term potentiation models in the development of memory-improving drugsArjan Blokland, Frank Boess
Neuroscience and Biobehavioral Reviews|April 20, 2010
The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studiesInge Klinkenberg, Arjan Blokland
Behavioural Brain Research|October 18, 2022
Delay-dependent forgetting in object recognition and object location test is dependent on strain and testArjan Blokland, Thibaut Sesia
Current Neuropharmacology|April 15, 2016
Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous SystemVyara Todorova, Arjan Blokland
Handbook of Experimental Pharmacology|May 16, 2015
Declarative memoryWim J Riedel, Arjan Blokland
Behavioural Brain Research|August 11, 2004
A detailed analysis of rats' spatial memory in a probe trial of a Morris taskArjan Blokland, Elke Geraerts, Marin Been
Human Psychopharmacology|September 17, 2021
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non-wordsMonika Toth, Anke Sambeth, Arjan Blokland
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Behavioural Pharmacology|May 27, 2022
Cholinergic models of memory impairment in animals and man: scopolamine vs. biperidenArjan Blokland
Human Psychopharmacology|May 4, 2023
Can placebo or nocebo pills improve or impair cognition performance?Arjan Blokland
Psychopharmacology|February 22, 2011
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentInge Klinkenberg, Arjan Blokland
Expert Opinion on Drug Discovery|March 20, 2013
Use of behavioural and long-term potentiation models in the development of memory-improving drugsArjan Blokland, Frank Boess
Neuroscience and Biobehavioral Reviews|April 20, 2010
The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studiesInge Klinkenberg, Arjan Blokland
Behavioural Brain Research|October 18, 2022
Delay-dependent forgetting in object recognition and object location test is dependent on strain and testArjan Blokland, Thibaut Sesia
Current Neuropharmacology|April 15, 2016
Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous SystemVyara Todorova, Arjan Blokland
Handbook of Experimental Pharmacology|May 16, 2015
Declarative memoryWim J Riedel, Arjan Blokland
Behavioural Brain Research|August 11, 2004
A detailed analysis of rats' spatial memory in a probe trial of a Morris taskArjan Blokland, Elke Geraerts, Marin Been
Human Psychopharmacology|September 17, 2021
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non-wordsMonika Toth, Anke Sambeth, Arjan Blokland
Pageof 15